Chronic GvHD development was accompanied by an upregulation of CCR5 and CXCR3 on splenic T CD4+ and CD8+ cells and increased frequency and expression of CCR10 and CCR4 on dermal CD4+ T cells (Figures 4A–D). This evidence concerns the gene CXCR3 and graft versus host disease.